Gene · 7329
Papers3,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic modification in Parkinson's disease. | Front Cell Dev Biol | 2023 | 37351278 | PubTator, text mining | PubMed |
| SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages. | Theranostics | 2023 | 37351164 | PubTator, text mining | PubMed |
| Inflammation-related research within the field of bladder cancer: a bibliometric analysis. | Front Oncol | 2023 | 37350946 | PubTator, text mining | PubMed |
| SENP3-mediated deSUMOylation of c-Jun facilitates microglia-induced neuroinflammation after cerebral ischemia and reperfusion injury. | iScience | 2023 | 37332598 | PubTator, text mining | PubMed |
| Updated protein domain annotation of the PARP protein family sheds new light on biological function. | Nucleic Acids Res | 2023 | 37326024 | PubTator, text mining | PubMed |
| Therapeutic prospect on umbilical cord mesenchymal stem cells in animal model with primary ovarian insufficiency: a meta-analysis. | Front Med (Lausanne) | 2023 | 37324123 | PubTator, text mining | PubMed |
| SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. | Front Cell Dev Biol | 2023 | 37313439 | PubTator, text mining | PubMed |
| Updated benchmarking of variant effect predictors using deep mutational scanning. | Mol Syst Biol | 2023 | 37310135 | PubTator, text mining | PubMed |
| Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy? | Front Mol Neurosci | 2023 | 37305556 | PubTator, text mining | PubMed |
| HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. | Front Immunol | 2023 | 37304265 | PubTator, text mining | PubMed |
| Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic. | J Biol Chem | 2023 | 37247759 | PubTator, text mining | PubMed |
| Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. | Signal Transduct Target Ther | 2023 | 37244925 | PubTator, text mining | PubMed |
| SUMOtherapeutics for Ischemic Stroke. | Pharmaceuticals (Basel) | 2023 | 37242456 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
| The Formation and Function of Birnaviridae Virus Factories. | Int J Mol Sci | 2023 | 37239817 | PubTator, text mining | PubMed |
| The Ubiquitin-like Proteins of Saccharomyces cerevisiae. | Biomolecules | 2023 | 37238603 | PubTator, text mining | PubMed |
| Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry. | JACS Au | 2023 | 37234110 | PubTator, text mining | PubMed |
| Interplay between PML NBs and HIRA for H3.3 dynamics following type I interferon stimulus. | Elife | 2023 | 37227756 | PubTator, text mining | PubMed |
| TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis. | JCI Insight | 2023 | 37212280 | PubTator, text mining | PubMed |
| A heterozygous mutation in UBE2H in a patient with developmental delay leads to an aberrant brain development in zebrafish. | Hum Genomics | 2023 | 37208785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7329/papers?page=13